Hanson Kristopher
SEC Form 4 history across 1 companies, 8 transactions and 4 filings.
Available history · May 11, 2026 – Oct 15, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
MPLTMapLight Therapeutics, Inc. | Hanson KristopherGC | S · saleSEC filing ↗ | -$72.8kView disclosure → | |
MPLTMapLight Therapeutics, Inc. | Hanson KristopherGC | S · sale10b5-1 detectedSEC filing ↗ | -$192kView disclosure → | |
MPLTMapLight Therapeutics, Inc. | Hanson KristopherGC | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
MPLTMapLight Therapeutics, Inc. | Hanson KristopherGC | A · grantSEC filing ↗ | $0View disclosure → | |
MPLTMapLight Therapeutics, Inc. | Hanson KristopherGC | S · sale10b5-1 detectedSEC filing ↗ | -$177kView disclosure → | |
MPLTMapLight Therapeutics, Inc. | Hanson KristopherGC | S · sale10b5-1 detectedSEC filing ↗ | -$209kView disclosure → | |
MPLTMapLight Therapeutics, Inc. | Hanson KristopherGC | S · sale10b5-1 detectedSEC filing ↗ | -$24.2kView disclosure → | |
MPLTMapLight Therapeutics, Inc. | Hanson KristopherGC | S · sale10b5-1 detectedSEC filing ↗ | -$7.84kView disclosure → |
Latest Form 4 facts
Quick context from source filings
sale at MapLight Therapeutics, Inc. on Oct 15, 2026 valued at $72,882.
Review SEC filingNo open-market insider purchase is available.
Monthly open-market activity
Last 4 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| May 2026 | 0 | 4 | $0.00 | $419,263.08 | -$419,263.08 |
| Aug 2026 | 0 | 0 | $0.00 | $0.00 | $0.00 |
| Sep 2026 | 0 | 1 | $0.00 | $192,660.03 | -$192,660.03 |
| Oct 2026 | 0 | 1 | $0.00 | $72,881.60 | -$72,881.60 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
7 observations · May 11, 2026 – Oct 15, 2026. Window ends at the latest available report, not today.
View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| May 11, 2026 | 175,964 | May 12, 2026 | View transaction |
| May 11, 2026 | 175,118 | May 12, 2026 | View transaction |
| May 11, 2026 | 168,139 | May 12, 2026 | View transaction |
| May 11, 2026 | 162,331 | May 12, 2026 | View transaction |
| Aug 17, 2026 | 153,553 | Aug 19, 2026 | View transaction |
| Sep 16, 2026 | 137,044 | Sep 18, 2026 | View transaction |
| Oct 15, 2026 | 128,024 | Oct 16, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Hanson Kristopher Insider Activity FAQ
SEC Form 4 context
Who is Hanson Kristopher?
Hanson Kristopher is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001789970.
Which companies has Hanson Kristopher reported transactions for?
MapLight Therapeutics, Inc.
When was Hanson Kristopher's latest insider buy?
No open-market insider purchase is available for this period.
When was Hanson Kristopher's latest insider sale?
sale at MapLight Therapeutics, Inc. on Oct 15, 2026 valued at $72,882.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.